irbesartan
Generic: irbesartan
Labeler: macleods pharmaceuticals limitedDrug Facts
Product Profile
Brand Name
irbesartan
Generic Name
irbesartan
Labeler
macleods pharmaceuticals limited
Dosage Form
TABLET
Routes
Active Ingredients
irbesartan 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
33342-049
Product ID
33342-049_6838a6ad-aea4-4f3b-a3f8-466c76b41e75
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202254
Listing Expiration
2026-12-31
Marketing Start
2012-09-27
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
33342049
Hyphenated Format
33342-049
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
irbesartan (source: ndc)
Generic Name
irbesartan (source: ndc)
Application Number
ANDA202254 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (33342-049-07)
- 90 TABLET in 1 BOTTLE (33342-049-10)
- 500 TABLET in 1 BOTTLE (33342-049-15)
- 9 BLISTER PACK in 1 CARTON (33342-049-39) / 10 TABLET in 1 BLISTER PACK
- 3400 TABLET in 1 POUCH (33342-049-76)
Packages (5)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "6838a6ad-aea4-4f3b-a3f8-466c76b41e75", "openfda": {"nui": ["N0000000070", "N0000175561"], "upc": ["0333342049100", "0333342047106", "0333342048103"], "unii": ["J0E2756Z7N"], "rxcui": ["200094", "200095", "200096"], "spl_set_id": ["e8635a1c-ae06-4e23-99f7-e704f91d6f43"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (33342-049-07)", "package_ndc": "33342-049-07", "marketing_start_date": "20120927"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (33342-049-10)", "package_ndc": "33342-049-10", "marketing_start_date": "20130311"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (33342-049-15)", "package_ndc": "33342-049-15", "marketing_start_date": "20120927"}, {"sample": false, "description": "9 BLISTER PACK in 1 CARTON (33342-049-39) / 10 TABLET in 1 BLISTER PACK", "package_ndc": "33342-049-39", "marketing_start_date": "20120927"}, {"sample": false, "description": "3400 TABLET in 1 POUCH (33342-049-76)", "package_ndc": "33342-049-76", "marketing_start_date": "20190226"}], "brand_name": "Irbesartan", "product_id": "33342-049_6838a6ad-aea4-4f3b-a3f8-466c76b41e75", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]"], "product_ndc": "33342-049", "generic_name": "Irbesartan", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan", "active_ingredients": [{"name": "IRBESARTAN", "strength": "300 mg/1"}], "application_number": "ANDA202254", "marketing_category": "ANDA", "marketing_start_date": "20120927", "listing_expiration_date": "20261231"}